XML 79 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Summary of Significant Accounting Policies [Line Items]    
Deferred offering costs $ 500,000  
Impairment losses on long lived assets 0 $ 0
Research and development expense 63,992,000 46,024,000
Foreign currency transaction gains (losses) (100,000) 100,000
Unrecognized tax benefits $ 0 0
Change in Accounting Principle, Accounting Standards Update, Adopted [true false] true  
Change in Accounting Principle, Accounting Standards Update, Adoption Date Jan. 01, 2024  
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] true  
Accounting Standards Update [Extensible Enumeration] us-gaap:AccountingStandardsUpdate202307Member  
Lilly Agreement    
Summary of Significant Accounting Policies [Line Items]    
Research and development expense $ 0 $ 0